江秀娟,牛继国,呼永华.地塞米松对非小细胞肺癌化疗患者HIF-1α[J].中国肿瘤,2015,24(1):73-75.
地塞米松对非小细胞肺癌化疗患者HIF-1α
Effect of Dexamethasone on Level of Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor in Patients with Non-small Cell Lung Cancer
投稿时间:2014-09-04  
DOI:10.11735/j.issn.1004-0242.2015.01.A016
中文关键词:  非小细胞肺癌  地塞米松  低氧诱导因子-1α  血管内皮生长因子
英文关键词:NSCLC  dexamethasone  HIF-1α  VEGF
基金项目:甘肃省科技厅技术研究与开发专项计划项目(1105TCYa019)
作者单位
江秀娟 甘肃省肿瘤医院 
牛继国 甘肃省肿瘤医院 
呼永华 甘肃省肿瘤医院 
摘要点击次数: 2443
全文下载次数: 892
中文摘要:
      摘 要:[目的] 探讨地塞米松对非小细胞肺癌化疗患者低氧诱导因子-1α(HIF-1α) 和血管内皮生长因子(VEGF)表达的影响。[方法] 97例非小细胞肺癌患者随机分为单纯化疗组和地塞米松辅助化疗组,采用酶联免疫吸附试验(ELISA)分别测定两组患者治疗前及治疗后的血清 HIF-1α、VEGF水平。[结果] 治疗前两组患者HIF-1α及VEGF水平均未见统计学差异(P>0.05);治疗后地塞米松辅助化疗组HIF-1α及VEGF水平明显低于单纯化疗组(P<0.05)。地塞米松辅助化疗组有效率(44.00%)明显高于单纯化疗组(27.79%)(χ2=6.304,P<0.05)。[结论] 地塞米松使非小细胞肺癌患者HIF-1α、VEGF水平下降,提高了化疗近期效果。
英文摘要:
      Abstract:[Purpose] To investigate the effect of dexamethasone on level of hypoxia inducible factors-1α(HIF-1α) and vascular endothelial growth factor (VEGF) in chemotherapy of non-small-cell lung cancer( NSCLC ). [Methods] A total of 97 cases with NSCLC were divided into chemotherapy group and combined chemotherapy with dexamethasone . HIF-1α and VEGF level in two groups were detected by enzyme-linked immune sorbent assay in pre - and post-treatment. [Results] The HIF-1α and VEGF level were not significant difference in two groups before treatment(P>0.05). After treatment,the HIF-1α and VEGF level in combined chemotherapy with dexamethasone was lower than that in alone chemotherapy group with significant difference (P<0.05) .The effective rate in combined chemotherapy with dexamethasone was 44.00%,which was higher than that in 27.79% in chemotherapy group(χ2=6.304,P<0.05). [Conclusion] Dexamethasone can decrease the HIF-1α and VEGF level in patients with NSCLC,improved chemotherapy efficacy.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器